Treace Price To Sales Ratio from 2010 to 2024
| TMCI Stock | USD 4.69 0.24 4.87% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 4.14639399 | Current Value 3.94 | Quarterly Volatility 11.96643864 |
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 202.7 K, Interest Income of 5.6 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 3.94, Dividend Yield of 0.0 or PTB Ratio of 5.34. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
Treace | Price To Sales Ratio |
Latest Treace Medical's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Treace Medical Concepts over the last few years. Price to Sales Ratio is figured by comparing Treace Medical Concepts stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Treace Medical sales, a figure that is much harder to manipulate than other Treace Medical Concepts multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Treace Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.59 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Treace Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 25.46 | |
| Geometric Mean | 20.75 | |
| Coefficient Of Variation | 47.00 | |
| Mean Deviation | 10.24 | |
| Median | 33.14 | |
| Standard Deviation | 11.97 | |
| Sample Variance | 143.20 | |
| Range | 29.2005 | |
| R-Value | (0.83) | |
| Mean Square Error | 48.55 | |
| R-Squared | 0.69 | |
| Significance | 0.0001 | |
| Slope | (2.21) | |
| Total Sum of Squares | 2,005 |
Treace Price To Sales Ratio History
About Treace Medical Financial Statements
Investors use fundamental indicators, such as Treace Medical's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 4.15 | 3.94 |
Currently Active Assets on Macroaxis
| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Treace Medical Correlation against competitors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 3.213 | Quarterly Revenue Growth 0.06 | Return On Assets (0.17) | Return On Equity (0.49) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.